BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Askarpour M, Hadi A, Dehghani Kari Bozorg A, Sadeghi O, Sheikhi A, Kazemi M, Ghaedi E. Effects of l-carnitine supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Hum Hypertens 2019;33:725-34. [DOI: 10.1038/s41371-019-0248-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang DD, Mao YZ, He SM, Yang Y, Chen X. Quantitative efficacy of L-carnitine supplementation on glycemic control in type 2 diabetes mellitus patients. Expert Rev Clin Pharmacol 2021;14:919-26. [PMID: 33861163 DOI: 10.1080/17512433.2021.1917381] [Reference Citation Analysis]
2 Nachvak SM, Shabanpur M, Mostafai R, Heidari Moghaddam R, Moludi J. L-Carnitine supplementation reduces biomarkers of inflammatory and oxidative stress in patients with coronary artery disease: a randomised controlled trial. Arch Physiol Biochem 2020;:1-8. [PMID: 32816578 DOI: 10.1080/13813455.2020.1797102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Johri AM, Hétu MF, Heyland DK, Herr JE, Korol J, Froese S, Norman PA, Day AG, Matangi MF, Michos ED, LaHaye SA, Saunders FW, Spence JD. Progression of atherosclerosis with carnitine supplementation: a randomized controlled trial in the metabolic syndrome. Nutr Metab (Lond) 2022;19:26. [PMID: 35366920 DOI: 10.1186/s12986-022-00661-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li N, Zhao H. Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update. Front Med (Lausanne) 2021;8:689042. [PMID: 34434943 DOI: 10.3389/fmed.2021.689042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang DD, Wang TY, Yang Y, He SM, Wang YM. The Effects of L-Carnitine, Acetyl-L-Carnitine, and Propionyl-L-Carnitine on Body Mass in Type 2 Diabetes Mellitus Patients. Front Nutr 2021;8:748075. [PMID: 34820412 DOI: 10.3389/fnut.2021.748075] [Reference Citation Analysis]
6 Pereverzev AP, Shevchenko DA, Filippova AV, Kirichenko AA, Krotkova IF, Ostroumova OD. Levocarnitine for the Treatment of Polymorbid Patients. Racionalʹnaâ farmakoterapiâ v kardiologii 2020;16:139-46. [DOI: 10.20996/1819-6446-2020-02-11] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Choi M, Park S, Lee M. L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2020;12:E2795. [PMID: 32932644 DOI: 10.3390/nu12092795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Hoseini-Tavassol Z, Hasani-Ranjbar S. Targeting TMAO and its metabolic pathway for cardiovascular diseases treatment. J Diabetes Metab Disord 2021;20:1095-7. [PMID: 34178875 DOI: 10.1007/s40200-021-00819-x] [Reference Citation Analysis]
9 Ning Z, Song Z, Wang C, Peng S, Wan X, Liu Z, Lu A. How Perturbated Metabolites in Diabetes Mellitus Affect the Pathogenesis of Hypertension? Front Physiol 2021;12:705588. [PMID: 34483960 DOI: 10.3389/fphys.2021.705588] [Reference Citation Analysis]
10 Liu JH, Chen N, Guo YH, Guan XN, Wang J, Wang D, Xiu MH. Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia. J Psychiatr Res 2021;140:409-15. [PMID: 34144444 DOI: 10.1016/j.jpsychires.2021.06.001] [Reference Citation Analysis]